Update 2025: Hormone Replacement Therapy in Menopause

 Presenter

Dr. Jane Xia
BScPharm, PharmD, MBA, MSCP
Assistant Professor of Teaching, University of British Columbia

Dr. Jane Xia joined the Faculty of Pharmaceutical Sciences in January 2019. She holds a Bachelor of Science in Pharmacy from the University of British Columbia, an MBA from Simon Fraser University, and a PharmD from the University of Toronto. Her diverse pharmacy experience spans community, hospital, regulatory, and industry settings. In 2018, she led the launch of the Hepatitis C Screening Program at London Drugs, partnering with advocacy groups, healthcare teams, and specialists. Her professional interests encompass women’s health, particularly menopause care. She is also passionate about understanding the patient journey, fostering interprofessional collaboration, and exploring the evolving role of pharmacy business practices in healthcare.

Session Information

Description

This session provides pharmacists with essential knowledge on Hormone Replacement Therapy (HRT) by offering practical insights to support evidence-based, patient-centered care in menopause management. Attendees will learn to identify menopause symptoms suitable for HRT, distinguish between different estrogen and progesterone therapies, and apply current clinical guidelines to manage symptoms effectively. Additionally, the session highlights the value of interprofessional collaboration strategies to enhance patient care coordination and to improve treatment outcomes.

Learning Objectives

• Identify menopause-related symptoms that can be effectively addressed through hormone replacement therapy (HRT).
• Differentiate between the various estrogen and progesterone therapies used in HRT.
• Apply the latest clinical guidelines for managing menopausal symptoms with HRT.
• Utilize interprofessional team approaches to enhance care coordination and improve outcomes for patients receiving HRT.